Related Experiment Video

Updated: Aug 9, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Antiplatelet therapy in acute coronary syndromes without ST segment elevation]

Berrin Umman1

  • 1Department of Cardiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. berrinumman@hotmail.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|April 15, 2006
PubMed

Insights

Antiplatelet therapy is crucial for acute coronary syndromes, but patient responses vary significantly. Balancing the benefits of reducing cardiovascular events against bleeding risks is essential for effective treatment.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Acute coronary syndromes (ACS) involve plaque rupture and platelet aggregation.
  • Antiplatelet therapy is a critical treatment for ACS, including unstable angina and non-ST elevation myocardial infarction.

Purpose:

  • To review the role of antiplatelet agents in ACS management.
  • To highlight the interpatient variability in response to antiplatelet drugs.
  • To emphasize the need for personalized antiplatelet therapy balancing efficacy and safety.

Summary:

  • Aspirin, thienopyridines, and glycoprotein IIb/IIIa antagonists are key antiplatelet drug classes used in ACS.
  • Significant interpatient variability exists in the response to these agents, impacting clinical outcomes.
  • Optimizing antiplatelet therapy requires careful consideration of individual patient benefits versus bleeding risks.

Impact:

  • Improved understanding of antiplatelet drug variability can lead to more tailored ACS treatment strategies.
  • Personalized antiplatelet therapy has the potential to reduce cardiovascular events and mortality.
  • Ongoing research aims to further refine antiplatelet drug selection and dosing for ACS patients.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...